{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:50:07Z","timestamp":1791467407699,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.07.104","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T23:40:55Z","timestamp":1439250055000},"page":"5913-5919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Critical review of current and emerging quantification methods for the development of influenza vaccine candidates"],"prefix":"10.1016","volume":"33","author":[{"given":"Aziza P.","family":"Manceur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9110-8815","authenticated-orcid":false,"given":"Amine A.","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.07.104_bib0440","series-title":"Influenza (Seasonal). Fact sheet N\u030a211","author":"WHO","year":"2014"},{"issue":"5468","key":"10.1016\/j.vaccine.2015.07.104_bib0445","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.288.5468.1051","article-title":"Influenza B virus in seals","volume":"288","author":"Osterhaus","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0450","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12703\/P6-47","article-title":"Advances in influenza vaccination","volume":"6","author":"Reperant","year":"2014","journal-title":"F1000Prime Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0455","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1750-2659.2012.00375.x","article-title":"Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion","volume":"7","author":"Bodle","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.104_bib0460","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0465","first-page":"63","article-title":"Vaccines in historic evolution and perspective: a narrative of vaccine discoveries","volume":"3","author":"Hilleman","year":"2000","journal-title":"J Hum Virol"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2015.07.104_bib0470","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/S0264-410X(00)00508-9","article-title":"The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines","volume":"19","author":"Pau","year":"2001","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2015.07.104_bib0475","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/j.vaccine.2010.03.029","article-title":"Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing","volume":"28","author":"Le Ru","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.104_bib0480","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1586\/erv.12.24","article-title":"Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production","volume":"11","author":"Montomoli","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2015.07.104_bib0485","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/S0264-410X(98)00464-2","article-title":"Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium","volume":"17","author":"Voeten","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0490","first-page":"77","article-title":"Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells","volume":"98","author":"Voeten","year":"1999","journal-title":"Dev Biol Stand"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.104_bib0495","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/infdis\/jiv091","article-title":"Immunogenicity and safety of an EB66 cell-culture-derived A\/Indonesia\/5\/2005 (H5N1)-AS03-adjuvanted influenza vaccine: phase-I randomized trial","volume":"212","author":"Schuind","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2015\/504831","article-title":"Current and emerging cell culture manufacturing technologies for influenza vaccines","volume":"2015","author":"Mili\u00e1n","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0505","series-title":"FDA approves first seasonal influenza vaccine manufactured using cell culture technology","author":"FDA","year":"2012"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0510","series-title":"Flublok","author":"FDA","year":"2013"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.104_bib0515","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/pbi.12301","article-title":"Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants","volume":"13","author":"Le Mauff","year":"2014","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0520","first-page":"1","article-title":"Advances and challenges in the development and production of effective plant-based influenza vaccines","author":"Yusibov","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.104_bib0525","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4161\/hv.7.3.14207","article-title":"Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond","volume":"7","author":"Yusibov","year":"2011","journal-title":"Hum Vaccin"},{"issue":"12","key":"10.1016\/j.vaccine.2015.07.104_bib0530","doi-asserted-by":"crossref","first-page":"e91555","DOI":"10.1371\/journal.pone.0015559","article-title":"Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza","volume":"5","author":"Landry","year":"2010","journal-title":"PLoS ONE"},{"issue":"3-4","key":"10.1016\/j.vaccine.2015.07.104_bib0535","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-1135(93)90027-5","article-title":"Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines","volume":"37","author":"Williams","year":"1993","journal-title":"Vet Microbiol"},{"issue":"3 Suppl.","key":"10.1016\/j.vaccine.2015.07.104_bib0540","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0264-410X(85)90114-8","article-title":"Quantification of haemagglutinin of influenza Tween\u2013ether split vaccines by immunodiffusion","volume":"3","author":"Johannsen","year":"1985","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0545","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2012.02.005","article-title":"Broadly neutralizing antibodies against influenza virus and prospects for universal therapies","volume":"2","author":"Ekiert","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.104_bib0550","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.104_bib0555","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.104_bib0560","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2015.07.104_bib0565","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS ONE"},{"issue":"6044","key":"10.1016\/j.vaccine.2015.07.104_bib0570","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.104_bib0575","doi-asserted-by":"crossref","first-page":"e3501000","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS Pathog"},{"issue":"6044","key":"10.1016\/j.vaccine.2015.07.104_bib0580","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.vaccine.2015.07.104_bib0585","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6100","key":"10.1016\/j.vaccine.2015.07.104_bib0590","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"issue":"48","key":"10.1016\/j.vaccine.2015.07.104_bib0595","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1016\/j.vaccine.2008.09.015","article-title":"Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins","volume":"26","author":"Chun","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0600","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2010.11.030","article-title":"Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus","volume":"403","author":"Hashem","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.104_bib0605","doi-asserted-by":"crossref","first-page":"e161096","DOI":"10.1371\/journal.pone.0109616","article-title":"Titer on chip: new analytical tool for influenza vaccine potency determination","volume":"9","author":"Kuck","year":"2014","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0610","doi-asserted-by":"crossref","first-page":"e85542","DOI":"10.1371\/journal.pone.0055428","article-title":"A novel synthetic receptor-based immunoassay for influenza vaccine quantification","volume":"8","author":"Hashem","year":"2013","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.104_bib0615","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/irv.12272","article-title":"A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines","volume":"8","author":"Schmeisser","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"issue":"50","key":"10.1016\/j.vaccine.2015.07.104_bib0620","doi-asserted-by":"crossref","DOI":"10.3791\/2784","article-title":"Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays","author":"Gravel","year":"2011","journal-title":"J Vis Exp"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.104_bib0625","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nprot.2009.200","article-title":"A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide","volume":"5","author":"Li","year":"2010","journal-title":"Nat Protoc"},{"issue":"9","key":"10.1016\/j.vaccine.2015.07.104_bib0630","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.vaccine.2015.01.034","article-title":"Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines","volume":"33","author":"Gravel","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.104_bib0635","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/CMR.00027-09","article-title":"Modern uses of electron microscopy for detection of viruses","volume":"22","author":"Goldsmith","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0640","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1099\/00221287-11-2-325","article-title":"Some properties of influenza virus filaments shown by electron microscopic particle counts","volume":"11","author":"Donald","year":"1954","journal-title":"J Gen Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0645","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1099\/00221287-12-2-241","article-title":"Particle counts of haemagglutinating viruses","volume":"12","author":"Isaacs","year":"1955","journal-title":"J Gen Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0650","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/j.1460-2075.1994.tb06264.x","article-title":"Fine structure of influenza A virus observed by electron cryo-microscopy","volume":"13","author":"Fujiyoshi","year":"1994","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0655","doi-asserted-by":"crossref","first-page":"e88828","DOI":"10.1371\/journal.pone.0088288","article-title":"Morphology of influenza B\/Lee\/40 determined by cryo-electron microscopy","volume":"9","author":"Katz","year":"2014","journal-title":"PLOS ONE"},{"issue":"2427","key":"10.1016\/j.vaccine.2015.07.104_bib0660","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1126\/science.94.2427.22","article-title":"The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus","volume":"94","author":"Hirst","year":"1941","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.104_bib0665","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.75.1.49","article-title":"The quantitative determination of influenza virus and antibodies by means of red cell agglutination","volume":"75","author":"Hirst","year":"1942","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0670","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-10-141","article-title":"Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches","volume":"10","author":"Thompson","year":"2013","journal-title":"Virol J"},{"issue":"9","key":"10.1016\/j.vaccine.2015.07.104_bib0675","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.vaccine.2008.11.113","article-title":"HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines","volume":"27","author":"Kapteyn","year":"2009","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2015.07.104_bib0680","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.vaccine.2006.01.046","article-title":"Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method","volume":"24","author":"Kapteyn","year":"2006","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2015.07.104_bib0685","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1016\/j.vaccine.2011.02.090","article-title":"Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays","volume":"29","author":"Lorbetskie","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0690","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0021-9673(01)90879-9","article-title":"Gradient optimization principles in reversed-phase high-performance liquid chromatography and the separation of influenza virus components","volume":"266","author":"Phelan","year":"1983","journal-title":"J Chromatogr"},{"issue":"28","key":"10.1016\/j.vaccine.2015.07.104_bib0695","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1016\/j.vaccine.2012.04.073","article-title":"Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A\/Puerto Rico\/8\/34 virus transmembrane and stalk domains","volume":"30","author":"Jing","year":"2012","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2015.07.104_bib0700","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1016\/j.vaccine.2013.07.011","article-title":"Assessment of viral replication in eggs and HA protein yield of pre-pandemic H5N1 candidate vaccine viruses","volume":"31","author":"Jing","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0705","series-title":"Guidelines on stability evaluation of vaccines. WHO\/BS\/06.2049","author":"WHO","year":"2006"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0710","article-title":"Particle quantification of influenza viruses by high performance liquid chromatography","author":"Transfiguracion","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0715","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cyto.a.10115","article-title":"Flow cytometer for measurement of the light scattering of viral and other submicroscopic particles","volume":"57","author":"Steen","year":"2004","journal-title":"Cytometry A"},{"issue":"1-2","key":"10.1016\/j.vaccine.2015.07.104_bib0720","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-0934(99)00167-6","article-title":"Flow cytometric detection of viruses","volume":"85","author":"Brussaard","year":"2000","journal-title":"J Virol Methods"},{"issue":"9","key":"10.1016\/j.vaccine.2015.07.104_bib0725","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI67042","article-title":"Nanoparticle-based flow virometry for the analysis of individual virions","volume":"123","author":"Arakelyan","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0730","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1038\/ncomms7022","article-title":"Sorting of small infectious virus particles by flow virometry reveals distinct infectivity profiles","volume":"6","author":"Gaudin","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.104_bib0735","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/v7030857","article-title":"Evaluation of ViroCyt(R) virus counter for rapid filovirus quantitation","volume":"7","author":"Rossi","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2015.07.104_bib0740","first-page":"50","article-title":"Comparing H1N1 virus quantification with a unique flow cytometer and quantitative PCR","volume":"9","author":"Stepp","year":"2011","journal-title":"Bioprocess"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0745","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/cyto.a.20145","article-title":"Design and characterization of a compact dual channel virus counter","volume":"65","author":"Stoffel","year":"2005","journal-title":"Cytometry A"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0750","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tcb.2008.11.003","article-title":"Shedding microvesicles: artefacts no more","volume":"19","author":"Cocucci","year":"2009","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.104_bib0755","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3402\/jev.v3.25011","article-title":"Comparative analysis of discrete exosome fractions obtained by differential centrifugation","volume":"3","author":"Jeppesen","year":"2014","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0760","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-0934(01)00316-0","article-title":"Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays","volume":"96","author":"LaBarre","year":"2001","journal-title":"J Virol Methods"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.07.104_bib0765","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jviromet.2008.03.006","article-title":"Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca\/ts phenotype","volume":"150","author":"Mo","year":"2008","journal-title":"J Virol Methods"},{"issue":"RR-8","key":"10.1016\/j.vaccine.2015.07.104_bib0770","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.104_bib0775","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3947\/ic.2013.45.4.375","article-title":"Influenza vaccines: unmet needs and recent developments","volume":"45","author":"Noh","year":"2013","journal-title":"Infect Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.104_bib0780","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.aca.2008.06.005","article-title":"Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance","volume":"623","author":"Mandenius","year":"2008","journal-title":"Anal Chim Acta"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.104_bib0785","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.vaccine.2009.10.070","article-title":"A novel assay for influenza virus quantification using surface plasmon resonance","volume":"28","author":"Nilsson","year":"2010","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2015.07.104_bib0790","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1016\/j.vaccine.2012.05.036","article-title":"Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC\u2013MSE","volume":"30","author":"Creskey","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.104_bib0795","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/irv.12001","article-title":"Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines","volume":"7","author":"Getie-Kebtie","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0800","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.biologicals.2009.12.005","article-title":"Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass spectrometry","volume":"38","author":"Garcia-Canas","year":"2010","journal-title":"Biologicals"},{"issue":"9","key":"10.1016\/j.vaccine.2015.07.104_bib0805","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1021\/ac4040778","article-title":"Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic","volume":"86","author":"Santana","year":"2014","journal-title":"Anal Chem"},{"issue":"14","key":"10.1016\/j.vaccine.2015.07.104_bib0810","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.vaccine.2011.12.056","article-title":"Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry","volume":"30","author":"Williams","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2015.07.104_bib0815","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1021\/ac2006526","article-title":"Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography\u2013tandem mass spectrometry","volume":"83","author":"Pierce","year":"2011","journal-title":"Anal Chem"},{"issue":"20","key":"10.1016\/j.vaccine.2015.07.104_bib0820","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.vaccine.2008.03.014","article-title":"Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry","volume":"26","author":"Williams","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.104_bib0825","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tibtech.2011.11.004","article-title":"Physical analysis of virus particles using electrospray differential mobility analysis","volume":"30","author":"Pease","year":"2012","journal-title":"Trends Biotechnol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.104_bib0830","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/bit.22085","article-title":"Quantitative characterization of virus-like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopy","volume":"102","author":"Pease","year":"2009","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0835","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jviromet.2013.07.026","article-title":"Quantitation of influenza virus using field flow fractionation and multi-angle light scattering for quantifying influenza A particles","volume":"193","author":"Bousse","year":"2013","journal-title":"J Virol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.104_bib0840","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/btpr.499","article-title":"Improved particle counting and size distribution determination of aggregated virus populations by asymmetric flow field-flow fractionation and multiangle light scattering techniques","volume":"27","author":"McEvoy","year":"2011","journal-title":"Biotechnol Prog"},{"issue":"1-2","key":"10.1016\/j.vaccine.2015.07.104_bib0845","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jviromet.2007.04.008","article-title":"Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution and infectivity","volume":"144","author":"Wei","year":"2007","journal-title":"J Virol Methods"},{"issue":"6","key":"10.1016\/j.vaccine.2015.07.104_bib0850","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/nar\/30.6.1292","article-title":"Real-time PCR in virology","volume":"30","author":"Mackay","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.104_bib0855","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/JCM.39.1.196-200.2001","article-title":"Simultaneous detection of influenza viruses A and B using real-time quantitative PCR","volume":"39","author":"van Elden","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.104_bib0860","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1469-0691.2010.03169.x","article-title":"Pandemic A(H1N1)2009 influenza virus detection by real time RT-PCR: is viral quantification useful?","volume":"16","author":"Duchamp","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.104_bib0865","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcv.2012.09.011","article-title":"Virtual quantification of influenza A virus load by real-time RT-PCR","volume":"56","author":"Piralla","year":"2013","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.104_bib0870","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jmoldx.2012.11.007","article-title":"Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations","volume":"15","author":"van der Vries","year":"2013","journal-title":"J Mol Diagn"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T01:57:23Z","timestamp":1599443843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15011081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":87,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15011081"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical review of current and emerging quantification methods for the development of influenza vaccine candidates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}